Lifetime risks of cardiovascular disease
- PMID: 22276822
- PMCID: PMC3336876
- DOI: 10.1056/NEJMoa1012848
Lifetime risks of cardiovascular disease
Abstract
Background: The lifetime risks of cardiovascular disease have not been reported across the age spectrum in black adults and white adults.
Methods: We conducted a meta-analysis at the individual level using data from 18 cohort studies involving a total of 257,384 black men and women and white men and women whose risk factors for cardiovascular disease were measured at the ages of 45, 55, 65, and 75 years. Blood pressure, cholesterol level, smoking status, and diabetes status were used to stratify participants according to risk factors into five mutually exclusive categories. The remaining lifetime risks of cardiovascular events were estimated for participants in each category at each age, with death free of cardiovascular disease treated as a competing event.
Results: We observed marked differences in the lifetime risks of cardiovascular disease across risk-factor strata. Among participants who were 55 years of age, those with an optimal risk-factor profile (total cholesterol level, <180 mg per deciliter [4.7 mmol per liter]; blood pressure, <120 mm Hg systolic and 80 mm Hg diastolic; nonsmoking status; and nondiabetic status) had substantially lower risks of death from cardiovascular disease through the age of 80 years than participants with two or more major risk factors (4.7% vs. 29.6% among men, 6.4% vs. 20.5% among women). Those with an optimal risk-factor profile also had lower lifetime risks of fatal coronary heart disease or nonfatal myocardial infarction (3.6% vs. 37.5% among men, <1% vs. 18.3% among women) and fatal or nonfatal stroke (2.3% vs. 8.3% among men, 5.3% vs. 10.7% among women). Similar trends within risk-factor strata were observed among blacks and whites and across diverse birth cohorts.
Conclusions: Differences in risk-factor burden translate into marked differences in the lifetime risk of cardiovascular disease, and these differences are consistent across race and birth cohorts. (Funded by the National Heart, Lung, and Blood Institute.).
Figures
Comment in
-
Lifetime risks of cardiovascular disease.N Engl J Med. 2012 Apr 26;366(17):1641; author reply 1642-3. doi: 10.1056/NEJMc1202276. N Engl J Med. 2012. PMID: 22533587 No abstract available.
-
Lifetime risks of cardiovascular disease.N Engl J Med. 2012 Apr 26;366(17):1642; author reply 1642-3. doi: 10.1056/NEJMc1202276. N Engl J Med. 2012. PMID: 22533588 No abstract available.
-
Lifetime risks of cardiovascular disease.N Engl J Med. 2012 Apr 26;366(17):1642; author reply 1642-3. doi: 10.1056/NEJMc1202276. N Engl J Med. 2012. PMID: 22533589 No abstract available.
Similar articles
-
Lifetime risk for heart failure among white and black Americans: cardiovascular lifetime risk pooling project.J Am Coll Cardiol. 2013 Apr 9;61(14):1510-7. doi: 10.1016/j.jacc.2013.01.022. J Am Coll Cardiol. 2013. PMID: 23500287 Free PMC article.
-
Lifetime Risks for Hypertension by Contemporary Guidelines in African American and White Men and Women.JAMA Cardiol. 2019 May 1;4(5):455-459. doi: 10.1001/jamacardio.2019.0529. JAMA Cardiol. 2019. PMID: 30916719 Free PMC article.
-
Lifetime risk and years lived free of total cardiovascular disease.JAMA. 2012 Nov 7;308(17):1795-801. doi: 10.1001/jama.2012.14312. JAMA. 2012. PMID: 23117780 Free PMC article.
-
Sick Populations and Sick Subpopulations: Reducing Disparities in Cardiovascular Disease Between Blacks and Whites in the United States.Circulation. 2016 Aug 9;134(6):472-85. doi: 10.1161/CIRCULATIONAHA.115.018102. Epub 2016 Jun 20. Circulation. 2016. PMID: 27324491 Free PMC article.
-
Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large cohorts of young adult and middle-aged men and women.JAMA. 1999 Dec 1;282(21):2012-8. doi: 10.1001/jama.282.21.2012. JAMA. 1999. PMID: 10591383
Cited by
-
Male Gender Expressivity and Diagnosis and Treatment of Cardiovascular Disease Risks in Men.JAMA Netw Open. 2024 Oct 1;7(10):e2441281. doi: 10.1001/jamanetworkopen.2024.41281. JAMA Netw Open. 2024. PMID: 39453653 Free PMC article.
-
[Cardiovascular prevention in old age].Z Gerontol Geriatr. 2024 Oct;57(6):447-451. doi: 10.1007/s00391-024-02355-8. Epub 2024 Sep 16. Z Gerontol Geriatr. 2024. PMID: 39283336 German.
-
Vascular endothelial function and its response to moderate-intensity aerobic exercise in trained and untrained healthy young men.Sci Rep. 2024 Sep 3;14(1):20450. doi: 10.1038/s41598-024-71471-7. Sci Rep. 2024. PMID: 39242762 Free PMC article.
-
The lifetime risk of surgery in England: a nationwide observational cohort study.Br J Anaesth. 2024 Oct;133(4):768-775. doi: 10.1016/j.bja.2024.06.028. Epub 2024 Jul 31. Br J Anaesth. 2024. PMID: 39084928 Free PMC article.
-
Efficacy of antiobesity medications among breast cancer survivors taking aromatase inhibitors.Breast Cancer Res Treat. 2024 Dec;208(3):553-563. doi: 10.1007/s10549-024-07450-3. Epub 2024 Jul 30. Breast Cancer Res Treat. 2024. PMID: 39080119
References
-
- Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): final report. Circulation. 2002;106:3143–3421. - PubMed
-
- Berry JD, Liu K, Folsom AR, et al. Prevalence and progression of subclinical atherosclerosis in younger adults with low short-term but high lifetime risk for cardiovascular disease: the Coronary Artery Risk Development in Young Adults Study and Multi-Ethnic Study of Atherosclerosis. Circulation. 2009;119:382–389. - PMC - PubMed
-
- Beiser A, D’Agostino RB, Sr, Seshadri S, Sullivan LM, Wolf PA. Computing estimates of incidence, including lifetime risk: Alzheimer’s disease in the Framingham Study: the Practical Incidence Estimators (PIE) macro. Stat Med. 2000;19:1495–1522. - PubMed
-
- Gaynor JJ, Feuer EJ, Tan CC, et al. On the use of cause-specific failure and conditional failure probabilities: examples from clinical oncology data. J Am Stat Assoc. 1993;88:400–409.
Publication types
MeSH terms
Grants and funding
- N01-HC-85085/HC/NHLBI NIH HHS/United States
- N01-WH-32113/WH/WHI NIH HHS/United States
- N01-HC-85081/HC/NHLBI NIH HHS/United States
- N01-WH-42110/WH/WHI NIH HHS/United States
- N01-HC-35129/HC/NHLBI NIH HHS/United States
- N01-WH-42119/WH/WHI NIH HHS/United States
- N01-WH-44221/WH/WHI NIH HHS/United States
- N01-WH-42117/WH/WHI NIH HHS/United States
- N01-WH-32112/WH/WHI NIH HHS/United States
- N01-WH-32118/WH/WHI NIH HHS/United States
- N01-WH-42114/WH/WHI NIH HHS/United States
- R01 HL043232/HL/NHLBI NIH HHS/United States
- N01-WH-32105/WH/WHI NIH HHS/United States
- N01-WH-42125/WH/WHI NIH HHS/United States
- N01-WH-32115/WH/WHI NIH HHS/United States
- U01 HL080295/HL/NHLBI NIH HHS/United States
- N01-WH-42126/WH/WHI NIH HHS/United States
- N01-WH-32102/WH/WHI NIH HHS/United States
- N01-WH-42120/WH/WHI NIH HHS/United States
- N01-WH-42131/WH/WHI NIH HHS/United States
- UL1 RR025741/RR/NCRR NIH HHS/United States
- N01-WH-42121/WH/WHI NIH HHS/United States
- N01-WH-42115/WH/WHI NIH HHS/United States
- R01 HL068140-05/HL/NHLBI NIH HHS/United States
- N01-HC-85086/HC/NHLBI NIH HHS/United States
- N01-HC-15103/HC/NHLBI NIH HHS/United States
- N01HC85086/HL/NHLBI NIH HHS/United States
- K23 HL092229/HL/NHLBI NIH HHS/United States
- N01-WH-42113/WH/WHI NIH HHS/United States
- N01-WH-42124/WH/WHI NIH HHS/United States
- N01-WH-42107/WH/WHI NIH HHS/United States
- N01-WH-42132/WH/WHI NIH HHS/United States
- N01-HC-85082/HC/NHLBI NIH HHS/United States
- N01-WH-42111/WH/WHI NIH HHS/United States
- K23 HL092229-04/HL/NHLBI NIH HHS/United States
- N01-WH-42116/WH/WHI NIH HHS/United States
- N01-HC-55222/HC/NHLBI NIH HHS/United States
- N01-WH-42109/WH/WHI NIH HHS/United States
- N01-WH-32101/WH/WHI NIH HHS/United States
- N01-HC-85083/HC/NHLBI NIH HHS/United States
- N01-HC-75150/HC/NHLBI NIH HHS/United States
- N01-WH-32108/WH/WHI NIH HHS/United States
- N01-HC-85080/HC/NHLBI NIH HHS/United States
- N01-WH-42130/WH/WHI NIH HHS/United States
- R01-HL68140/HL/NHLBI NIH HHS/United States
- N01-WH-32111/WH/WHI NIH HHS/United States
- N01-WH-42122/WH/WHI NIH HHS/United States
- N01-WH-32106/WH/WHI NIH HHS/United States
- N01-WH-32122/WH/WHI NIH HHS/United States
- N01-WH-32100/WH/WHI NIH HHS/United States
- N01-WH-42123/WH/WHI NIH HHS/United States
- N01-HC-45133/HC/NHLBI NIH HHS/United States
- N01-WH-42112/WH/WHI NIH HHS/United States
- N01-HC-85079/HC/NHLBI NIH HHS/United States
- R21 HL085375/HL/NHLBI NIH HHS/United States
- N01-WH-42108/WH/WHI NIH HHS/United States
- N01-WH-22110/WH/WHI NIH HHS/United States
- N01-WH-32119/WH/WHI NIH HHS/United States
- N01HC85079/HL/NHLBI NIH HHS/United States
- R01 HL068140/HL/NHLBI NIH HHS/United States
- N01WH22110/WH/WHI NIH HHS/United States
- N01-HC-85084/HC/NHLBI NIH HHS/United States
- R21 HL085375-02/HL/NHLBI NIH HHS/United States
- N01-WH-24152/WH/WHI NIH HHS/United States
- N01-WH-42129/WH/WHI NIH HHS/United States
- N01-WH-42118/WH/WHI NIH HHS/United States
- N01-WH-32109/WH/WHI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources